Skip to content
Screener

Savara SVRA Total Equity

Total Equity at other companies

XER
Xeris Biopharma Holdings, Inc.XERS
-$9.73M+49.6%
Innoviva, Inc. logo
Innoviva, Inc.INVA
$1.23B
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$217.65M+85.7%
Upstream Bio, Inc. logo
Upstream Bio, Inc.UPB
$304M-31.8%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$597.21M+36.7%
PVL
Palvella TherapeuticsPVLA
$232.31M+318%

Other financials

Income statement

See full
Revenue-
Operating income-$39.0M-37.1%
Net income-$37.3M-40.0%
EPS (diluted)-$0.15-25.0%

Balance sheet

See full
Cash & equivalents$38.8M+98.4%
Total debt$30.1M+1.8%
Total assets$221.6M+17.1%

Cash flow

See full
Operating cash flow-$33.0M-21.5%
CapEx$54.0K+1,700%
Free cash flow-$33.1M-21.7%

Valuation

See full
Market cap$1.19B+151%
Enterprise value$1.18B+142%

Profitability

See full
Operating margin-19,183.3%
Net margin-19,305.1%
FCF margin-15,518.7%

Returns & leverage

See full
Return on equity-80%+4.7pp
Debt / equity0.2×0.0×
Current ratio13.5×-1.4×

Where this comes from

Reported directly by Savara in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The source filing: Savara’s 10-Q, filed May 12, 2026.

Filed
May 12, 2026, 4:05 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-219371
Line itemMarch 31, 2026December 31, 2025
Commitments and contingencies (Note 9)
Stockholders’ equity:
Common stock, $0.001 par value, 300,000,000 authorized as of March 31, 2026 and December 31, 2025; 204,922,140 and 204,567,283 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively204204
Additional paid-in capital821,635811,103
Accumulated other comprehensive loss(429)(87)
Accumulated deficit(645,371)(608,087)
Total stockholders' equity176,039203,133
Total liabilities and stockholders' equity$221,645$253,436

Cover / Front Matter

FAQ

What is Savara's total equity?
Savara (SVRA) reported total equity of $176.04M in Q1 2026.
How has Savara's total equity changed year-over-year?
Savara's total equity increased by 19.1% year-over-year, from $147.85M to $176.04M.
What is the long-term trend for Savara's total equity?
Over 5 years (2020 to 2025), Savara's total equity has grown at a 25.8% compound annual growth rate (CAGR), from $64.38M to $203.13M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Ask your AI about Savara's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude